NeoTYPE™ Cancer Profiles are multi-method test panels, custom-designed for a specific tumor type, that identify the genetic changes most significant to therapy decisions, prognosis, and clinical research. Read more.
This test is performed by bidirectional sequencing of select exons of the genes listed, plus the CLL FISH Panel and ZAP-70 flow cytometry as noted. Concise Profile includes: IgVH, NOTCH1, SF3B1, CLL FISH. Comprehensive Profile includes added: ZAP-70 flow. Test orders include summary interpretation of all results together. Molecular-only test options are available for the Comprehensive and Concise Profiles. Any tests may be ordered separately; these will be reported individually without summary interpretation.
Read more about the NeoTYPE™ CLL Prognostic Profile.